Evidence of Durable Vision Improvement With Gene Therapy for Retinitis Pigmentosa

(MedPage Today) -- CHICAGO--A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed.
After 52 weeks of follow-up...